Continuous nanostructures for the controlled release of drugs

Current Pharmaceutical Design

Volumn 15, Issue 15, 2009, Pages 1799-1808

  Venugopal, J ^a   Prabhakaran, Molamma P ^a   Low, Sharon ^b   Choon, Aw Tar ^b,c,d   Deepika, G ^a   Dev, V R Giri ^a   Ramakrishna, S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b StemLife Sdn Bhd   (Malaysia)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Controlled release; Drugs; Electrospinning; Nanofibers; Nanoparticle; Polymers

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CARMUSTINE; CEFOXITIN; CHITOSAN; DNA; DOXORUBICIN; DRUG CARRIER; ETHYLENE VINYL ALCOHOL COPOLYMER; GENTAMICIN; IBUPROFEN; ITRACONAZOLE; LIPOSOME; NANOFIBER; NANOMATERIAL; NANOPARTICLE; NERVE GROWTH FACTOR; NITROXOLINE; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR AA; POLYLACTIC ACID; PROGESTERONE; RESVERATROL; TETRACYCLINE; TOBRAMYCIN; DRUG; POLYMER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINEOPLASTIC ACTIVITY; BIODEGRADABILITY; BRAIN TUMOR; BREAST CANCER; CANCER SURVIVAL; CHILL; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FEVER; DRUG HALF LIFE; DRUG INCOMPATIBILITY; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; GENE EXPRESSION; GENE THERAPY; GLIOBLASTOMA; HEMOLYSIS; HUMAN; HYDROPHILICITY; LIPOSOMAL DELIVERY; LIPOSOMAL GENE DELIVERY SYSTEM; LOW DRUG DOSE; NANOTECHNOLOGY; NEPHROTOXICITY; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TIMED DRUG RELEASE; VOMITING; WOUND HEALING; CHEMISTRY; DELAYED RELEASE FORMULATION; METHODOLOGY;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 67650621518     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788186344     Document Type: Review

References (81)

1. Scheindlin S. Transdermal drug delivery: Past, Present, Future, Molecular Interventions. 2004; 4: 308-12.
2. Wagner W, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006; 24: 1211-7.
3. Wickramasinghe N, Choudhary S, Geisler E. Bionanotechnology: Its applications and relevance to healthcare. Int J Biomedical Eng Tech 2007; 1: 41-58.
4. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine 2005; 1: 22-30.
5. Kumbar SG, Nair LS, Bhattacharyya S, Laurencin CT. Polymeric nanofibers as novel carriers for the delivery of therapeutic molecules. J Nanosci Nanotech 2006; 6: 2591-607.
6. Peppas NA, Langer R. New challenges in biomaterials. Science 1994; 263: 1715-20.
7. Kenawy el-R, Bowlin GL, Simpson DG, Wnek GE. Release of tetracycline hydrochloride from electrospun poly(ethylene-covinylacetate), poly(lactic acid), and a blend. J Control Release 2002; 81: 57-64.
8. Jiang H, Fang D, Hsiao B, Chen W, Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan electrospun membranes. J Biomater Sci Polym Edn 2004; 15: 279-96.
9. Zeng J, Xu X, Jing X, Biodegradable electrospun fibers for drug delivery. J Control Release 2003; 92: 227-31.
10. Xie J, Wang C. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res 2006; 23: 1817-26.
11. Huang Z, He C, Zhang Y, Wu Q. Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J Biomed Mater.Res 2006; 77A: 169-79.
12. Maretschek S, Greiner A, Kissel T. Electrospun biodegradable nanofibers nonwovens for controlled release of proteins. J Control Release 2008; 127: 180-87.
13. Ghosh TK, Pfister WR, Yum SI, Eds. Transdermal and topical Drug Delivery Systems, Interpharm Press: Buffalo Grove, IL 1997.
14. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Edn 2007; 18: 241-68.
15. Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Bimol Eng 2006; 23: 171-84.
16. Qiu. Y, Bae YH. Polymer architecture and drug delivery. Pharm Res 2006; 23: 1-30.
17. Lee JH, Jung SW, Kim SH. Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier. Int J Pharm 2003; 251: 23-32.
18. Vaseashta A, Stamatin I. Electrospun polymers for controlled release of drugs, vaccine delivery and system-on-fibers. J Optoelect Adv Mater. 2007; 9: 1606-13.
19. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 2002; 19: 425-98.
20. Senior K. "Nano-dumpling" with drug delivery potential. Mol Med Today 1998; 4: 321.
21. Lavan DA, McGuire T, Langer R. Small scale systems for in vivo drug delivery. Nat Biotechnol 2003; 21: 1184-91.
22. Drummond DC, Meyer O, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999; 51: 691-743.
23. Soppimath KS, Kulkarni AR, Aminabhavi TM. Chemically modified polyacrylamide-g-guar gum-based crosslinked anionic microgels as pH-sensitive drug delivery systems: Preparation and characterization. J Control Release 2001; 75: 331-45.
24. Katti DS, Robinson KW, Ko FK, Laurencin CT. Bioresorbable nanofiber based systems for wound healing and drug delivery: Optimization of fabrication parameters. J Biomed Mater.Res B Appl Biomater 2004; 70: 286-96.
25. Verreck G, Chun I, Peters J, Rosenblatt J, Brewster ME. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm Res 2003; 20: 810-17.
26. Zong X, Kim K, Chu B. Structure and process relationship of electrospun biodegradable nanofiber membranes. Polymer 2002; 43: 4403-12.
27. Kim K, Luu YK, Chu B, Hadjiargyrou M. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactic-coglycolide)-based electrospun nanofibrous scaffolds. J Control Release 2004; 98: 47-56.
28. Chew SY, Chen Y, Denis Y, Leong KW. The role of electrospinning in the emerging field of nanomedicine. Curr Pharm Des 2006; 12: 4751-70.
29. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov Today 2005; 10: 1435-42.
30. Langer R. Drug delivery and targeting. Nature 1998; 392: 5-10.
31. Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006; 58: 1456-59.
32. Yu JH, Fridrikh SV, Rutledge GC. Production of submicrometer diameter fibers by two-fluid electrospinning. Adv Mater. 2004; 16: 1562-66.
33. Viitanen P, Suokas E, Ashammakhi N. Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods. J Mater.Sci Mater. Med 2006; 17: 1267-74.
34. Brewster KE, Verreck G, Peeters J. The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. Pharmazie 2004; 59: 387-91.
35. Sapasova M, Manolova N, Paneva D, Rashkov L. Preparation of chitosan-containing nanofibers by electrospinning of chitosan/ poly(ethylene oxide) blend solutions. e-Polymers 2004; 056: 1-12.
36. Xu X, Chen X, Yang L. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells. J Control Release 2006; 114: 307-16.
37. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncol 2003; 5: 79-88.
38. Silber JB, Bobola MS, Berger MS. O6-methylguanine-DNA methyltransferase activity in adult gliomas: Relation to patient and tumor characteristics. Cancer Res 1998; 58: 1068-73.
39. Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002; 235: 179-92.
40. Cai D, Mataraza JM, Qin ZH, Huang Z, Kempa K, Ren Z. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods 2005; 2: 449-54.
41. Steiniger SCJ, Kreuter J, Khalansky AS, Gelperina SE. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004; 109: 759-67.
42. Petrak K. Nanotechnology and site-targeted drug delivery. J Biomater Sci Polym Edn 2006; 17: 1209-19.
43. Harries M, Ellis P, Harper P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J Clin Oncol 2005; 23: 7768-71.
44. Lee KH, Kim HY, Lee DR. Characterization of nano-structured poly(ε-caprolactone) nonwoven mats via electrospinning. Polymer 2003; 44: 1287-94.
45. Zeng J, Aigner A, Kissel T, Greiner A. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules 2005; 6: 1484-88.
46. Greisler HP, Gosselin C, Ren D, Kang SS, Du K. Bioactive polymers and tissue engineered blood vessels. Biomaterials 1996; 17: 329-36.
47. Labhasetwar V, Bonadio J, Goldstein S, Chen W, Levy RJ. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle. J Pharm Sci 1998; 11: 1347-50.
48. Rosner BI, Siegel RA, Grosberg A, Tranquillo RT. Rational design of contact guiding, neurotrophic matrices for peripheral nerve regeneration. Ann Biomed Eng 2003; 31: 1383-401.
49. Midha R, Munro CA, Dalton PD, Tator CH, Shoichet MS. Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J Neurosurg 2003; 99: 555-65.
50. Bender MD, Bennett JM, Waddell RL, Doctor JS, Marra KG. Multi-channeled biodegradable polymer/Cultisphere composite nerve guides. Biomaterials 2004; 25: 1269-78.
51. Verreck G, Chun I, Li Y, Brewster ME. Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials 2005; 26: 1307-15.
52. Nair L, Bhattacharyya S, Laurencin CT. Development of novel tissue engineering scaffolds via electrospinning. Expert Opin Biol Ther 2004; 4: 659-68.
53. Verreck G, Chun I, Rosenblatt J, Brewster ME. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water insoluble, nonbiodegradable polymer. J Control Release 2003; 92: 349-60.
54. Sun Z, Zussman E, Yarin AL, Greiner A. Compound core-shell polymer nanofibers by co-electrospinning. Adv Mater.2003; 22: 1929-32
55. Zhang YZ, Venugopal J, Lim CT, Huang ZM, Ramakrishna S. Characterization of the surface biocompatibility of the electrospun PCL-Collagen nanofibers using fibroblasts, Biomacromolecules 2005; 6: 2583-89.
56. Zhang YZ, Lim CT, Huang ZM, Ramakrishna S. Preparation of core-shell structured PCL-r-gelatin bi-component nanofibers by coaxial electrospinning. Chem Mater.2004; 16: 3406-409.
57. Gallis HA, Drew RH, Pickard WW, Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308-29.
58. Fukui H, Koike T, Saheki A, Sonoke S, Seki S. A novel delivery system for amphotericin B with lipid nano-sphere (LNS®). Int J Pharm 2003; 265: 37-45.
59. Silva SY, Rueda. C, Lopez-Jaramillo P. Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]. Trials 2006; 7: 7-14
60. Silva SY, Rueda LC, Lopez-Jaramillo P. Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON. Trials 2007; 8: 8-26.
61. Park SN, Kim JK, Suh H. Evaluation of antibiotic-loaded collagenhyaluronic acid matrix as a skin substitute. Biomaterials 2004; 25: 3689-98.
62. Tonetti M, Cugini MA, Goodson JM. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res 1990; 25: 243-49.
63. Ye Y, Anand SC, Horrocks AR. Using alginate as drug carrier for wound healing. In: Anand SC, Ed. Medical textiles. Cambridge: Woodhead Publishing Ltd. 1996; pp. 21-26.
64. Denkba EB, Seyya MI, Piskin E. Implantable 5-flurouracil loaded chitosan scaffolds prepared by wet spinning. J Membr Sci 2000; 172: 33-38.
65. Taepaiboon P, Rungsardthong U, Supaphol P. Drug-loaded electrospun mats of poly(vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology 2006; 17: 2317-29.
66. Richarson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-34.
67. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5: 753-59.
68. Clark RAF, Singer AJ. Wound repair: Basic biology to tissue engineering. In: Lanza RP, Langer R, Vacanti J, Eds. Principles of tissue engineering. San Diego: Academic Press 2000; pp. 857-78.
69. Williamson MR, Chang HI, Coombes AGA. Gravity spun polycaprolactone fibres: Controlling release of a hydrophilic macromolecules (ovalbumin) and a lipophilic drug (progesterone). Biomaterials 2004; 25: 5053-60.
70. Rubin CT. Goods and Goodies: The place of normative issues in technology development. Weblink: http://www.nano-andsociety.org/ commentaries/commentary_rubin01.html
71. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004; 94: 1-14.
72. Aquino RD. Good drug therapy: It's not just the molecule-it's the delivery. CEP Magazine 2004; 100: 15S-17S.
73. Kushibiki T, Tabata Y. Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier. J Biomater Sci Polym Edn 2005; 16: 1447-61.
74. Mao HQ, Roy K, Leong KW. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70: 399-421.
75. Truong-Le VL, August JT, Leong KW. Controlled gene delivery by DNA-gelatin nanospheres. Hum Gene Ther 1998; 9: 1709-17.
76. Cohen H, Levy RJ, Gao J, Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 2000; 7: 1896-905.
77. Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm 2002; 244: 105-15.
78. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2002; 55: 329-47.
79. Panyam J, Zhou WZ, Prabha S, Labhasetwar V. Rapid endolysosomal escape of poly(D,L-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J 2002; 16: 1217-26.
80. Grotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues. J Microencapsul 1998; 15: 699-713.
81. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5-24.